[(1S,5S,6S,7S,8S,10S,11S,13R,16S)-7-hydroxy-11,15,18,18-tetramethyl-10,13,16-tris[(2-methylpropan-2-yl)oxycarbonyloxy]-3,12-dioxo-2,4-dioxatetracyclo[12.3.1.01,5.06,11]octadec-14-en-8-yl] acetate

C37H54O16 — CID 101479621

IUPAC[(1S,5S,6S,7S,8S,10S,11S,13R,16S)-7-hydroxy-11,15,18,18-tetramethyl-10,13,16-tris[(2-methylpropan-2-yl)oxycarbonyloxy]-3,12-dioxo-2,4-dioxatetracyclo[12.3.1.01,5.06,11]octadec-14-en-8-yl] acetate
SMILESCC(=O)O[C@H]1C[C@H](OC(=O)OC(C)(C)C)[C@@]2(C)C(=O)[C@H](OC(=O)OC(C)(C)C)C3=C(C)[C@@H](OC(=O)OC(C)(C)C)C[C@]4(OC(=O)O[C@H]4[C@@H]2[C@@H]1O)C3(C)C
InChIInChI=1S/C37H54O16/c1-17-20(46-28(41)50-32(3,4)5)16-37-27(49-31(44)53-37)23-24(39)19(45-18(2)38)15-21(47-29(42)51-33(6,7)8)36(23,14)26(40)25(22(17)35(37,12)13)48-30(43)52-34(9,10)11/h19-21,23-25,27,39H,15-16H2,1-14H3/t19-,20-,21-,23-,24+,25+,27-,36+,37+/m0/s1
InChIKeyNPNGQMXSKSTGEI-UZEWVWNDSA-N
MW754.82 g/mol
LogP5.87
Rot. Bonds4

About [(1S,5S,6S,7S,8S,10S,11S,13R,16S)-7-hydroxy-11,15,18,18-tetramethyl-10,13,16-tris[(2-methylpropan-2-yl)oxycarbonyloxy]-3,12-dioxo-2,4-dioxatetracyclo[12.3.1.01,5.06,11]octadec-14-en-8-yl] acetate

[(1S,5S,6S,7S,8S,10S,11S,13R,16S)-7-hydroxy-11,15,18,18-tetramethyl-10,13,16-tris[(2-methylpropan-2-yl)oxycarbonyloxy]-3,12-dioxo-2,4-dioxatetracyclo[12.3.1.01,5.06,11]octadec-14-en-8-yl] acetate (PubChem CID 101479621) has the molecular formula C37H54O16 and a molecular weight of 754.82 g/mol. Its IUPAC name is [(1S,5S,6S,7S,8S,10S,11S,13R,16S)-7-hydroxy-11,15,18,18-tetramethyl-10,13,16-tris[(2-methylpropan-2-yl)oxycarbonyloxy]-3,12-dioxo-2,4-dioxatetracyclo[12.3.1.01,5.06,11]octadec-14-en-8-yl] acetate.

Molecular Properties

Compound Name[(1S,5S,6S,7S,8S,10S,11S,13R,16S)-7-hydroxy-11,15,18,18-tetramethyl-10,13,16-tris[(2-methylpropan-2-yl)oxycarbonyloxy]-3,12-dioxo-2,4-dioxatetracyclo[12.3.1.01,5.06,11]octadec-14-en-8-yl] acetate
PubChem CID101479621
Molecular FormulaC37H54O16
Molecular Weight754.82 g/mol
Exact Mass754.34
IUPAC Name[(1S,5S,6S,7S,8S,10S,11S,13R,16S)-7-hydroxy-11,15,18,18-tetramethyl-10,13,16-tris[(2-methylpropan-2-yl)oxycarbonyloxy]-3,12-dioxo-2,4-dioxatetracyclo[12.3.1.01,5.06,11]octadec-14-en-8-yl] acetate
SMILESCC(=O)O[C@H]1C[C@H](OC(=O)OC(C)(C)C)[C@@]2(C)C(=O)[C@H](OC(=O)OC(C)(C)C)C3=C(C)[C@@H](OC(=O)OC(C)(C)C)C[C@]4(OC(=O)O[C@H]4[C@@H]2[C@@H]1O)C3(C)C
InChIInChI=1S/C37H54O16/c1-17-20(46-28(41)50-32(3,4)5)16-37-27(49-31(44)53-37)23-24(39)19(45-18(2)38)15-21(47-29(42)51-33(6,7)8)36(23,14)26(40)25(22(17)35(37,12)13)48-30(43)52-34(9,10)11/h19-21,23-25,27,39H,15-16H2,1-14H3/t19-,20-,21-,23-,24+,25+,27-,36+,37+/m0/s1
InChIKeyNPNGQMXSKSTGEI-UZEWVWNDSA-N
XLogP5.87
TPSA205.72 Ų
H-Bond Donors1
H-Bond Acceptors16
Rotatable Bonds4
Heavy Atoms53
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500754.82
LogP ≤ 55.87
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1016

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze [(1S,5S,6S,7S,8S,10S,11S,13R,16S)-7-hydroxy-11,15,18,18-tetramethyl-10,13,16-tris[(2-methylpropan-2-yl)oxycarbonyloxy]-3,12-dioxo-2,4-dioxatetracyclo[12.3.1.01,5.06,11]octadec-14-en-8-yl] acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(1S,5S,6S,7S,8S,10S,11S,13R,16S)-7-hydroxy-11,15,18,18-tetramethyl-10,13,16-tris[(2-methylpropan-2-yl)oxycarbonyloxy]-3,12-dioxo-2,4-dioxatetracyclo[12.3.1.01,5.06,11]octadec-14-en-8-yl] acetate?
The IUPAC name of [(1S,5S,6S,7S,8S,10S,11S,13R,16S)-7-hydroxy-11,15,18,18-tetramethyl-10,13,16-tris[(2-methylpropan-2-yl)oxycarbonyloxy]-3,12-dioxo-2,4-dioxatetracyclo[12.3.1.01,5.06,11]octadec-14-en-8-yl] acetate (CID 101479621) is [(1S,5S,6S,7S,8S,10S,11S,13R,16S)-7-hydroxy-11,15,18,18-tetramethyl-10,13,16-tris[(2-methylpropan-2-yl)oxycarbonyloxy]-3,12-dioxo-2,4-dioxatetracyclo[12.3.1.01,5.06,11]octadec-14-en-8-yl] acetate.
What is the SMILES notation for [(1S,5S,6S,7S,8S,10S,11S,13R,16S)-7-hydroxy-11,15,18,18-tetramethyl-10,13,16-tris[(2-methylpropan-2-yl)oxycarbonyloxy]-3,12-dioxo-2,4-dioxatetracyclo[12.3.1.01,5.06,11]octadec-14-en-8-yl] acetate?
The canonical SMILES for [(1S,5S,6S,7S,8S,10S,11S,13R,16S)-7-hydroxy-11,15,18,18-tetramethyl-10,13,16-tris[(2-methylpropan-2-yl)oxycarbonyloxy]-3,12-dioxo-2,4-dioxatetracyclo[12.3.1.01,5.06,11]octadec-14-en-8-yl] acetate is CC(=O)O[C@H]1C[C@H](OC(=O)OC(C)(C)C)[C@@]2(C)C(=O)[C@H](OC(=O)OC(C)(C)C)C3=C(C)[C@@H](OC(=O)OC(C)(C)C)C[C@]4(OC(=O)O[C@H]4[C@@H]2[C@@H]1O)C3(C)C.
What is the InChIKey of [(1S,5S,6S,7S,8S,10S,11S,13R,16S)-7-hydroxy-11,15,18,18-tetramethyl-10,13,16-tris[(2-methylpropan-2-yl)oxycarbonyloxy]-3,12-dioxo-2,4-dioxatetracyclo[12.3.1.01,5.06,11]octadec-14-en-8-yl] acetate?
The InChIKey is NPNGQMXSKSTGEI-UZEWVWNDSA-N. The full InChI is InChI=1S/C37H54O16/c1-17-20(46-28(41)50-32(3,4)5)16-37-27(49-31(44)53-37)23-24(39)19(45-18(2)38)15-21(47-29(42)51-33(6,7)8)36(23,14)26(40)25(22(17)35(37,12)13)48-30(43)52-34(9,10)11/h19-21,23-25,27,39H,15-16H2,1-14H3/t19-,20-,21-,23-,24+,25+,27-,36+,37+/m0/s1.
What are the key properties of [(1S,5S,6S,7S,8S,10S,11S,13R,16S)-7-hydroxy-11,15,18,18-tetramethyl-10,13,16-tris[(2-methylpropan-2-yl)oxycarbonyloxy]-3,12-dioxo-2,4-dioxatetracyclo[12.3.1.01,5.06,11]octadec-14-en-8-yl] acetate?
[(1S,5S,6S,7S,8S,10S,11S,13R,16S)-7-hydroxy-11,15,18,18-tetramethyl-10,13,16-tris[(2-methylpropan-2-yl)oxycarbonyloxy]-3,12-dioxo-2,4-dioxatetracyclo[12.3.1.01,5.06,11]octadec-14-en-8-yl] acetate has a molecular weight of 754.82 g/mol, XLogP of 5.87, 4 rotatable bonds, 1 hydrogen bond donors, and 16 hydrogen bond acceptors.
Where does this data come from?
All data for [(1S,5S,6S,7S,8S,10S,11S,13R,16S)-7-hydroxy-11,15,18,18-tetramethyl-10,13,16-tris[(2-methylpropan-2-yl)oxycarbonyloxy]-3,12-dioxo-2,4-dioxatetracyclo[12.3.1.01,5.06,11]octadec-14-en-8-yl] acetate is sourced from PubChem (CID 101479621), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).